NCT07310914Not yet recruitingPhase 2
Implementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 30 Dec 2025
Brief summary (registry, in English)
The overall purpose of the present study is to investigate the effect of an advanced telerehablitation system (TRS) in persons with multiple sclerosis on mobility. The advanced telerhabilitation system is based on AI components, and delivers instant feedback to the partcipants. If the project is successful, it can help optimize exercise for those persons with multiple sclerosis who are either not able or willing to travel to a clinical setting for exericse.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 94 (estimated)
- First submitted
- 16 Dec 2025
- Start date
- 1 Feb 2026
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Danish Multiple Sclerosis Hospitals
- Diseases
- Multiple sclerosis
- NCT number
- NCT07310914
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 94
- From 1 Feb 2026 to the primary completion date, 31 Dec 2026
- 5 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- comorbidities hindering participation in the study.
- Individuals who have had a documented relapse and/or corticoid treatment during the past three months will be excluded,
- Individuals with severe cognitive deficits who cannot follow simple instructions and/or consent.
Who the study is looking for
- Definite diagnosis of MS according to the McDonald criteria (both relapse-remitting and progressive)
- Expanded Disability Status Scale (EDSS) score of 2.5 to 6.5 or Patient Determined Disability Score (PDDS) of 2 to 6, indicating preservation of at least some ambulatory function, that is, the ability to walk 20 meters or more, independently, with or without the use of an assistive device
- Willingness to travel to the local study site for the evaluation sessions,
- Internet platform availability
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Danish MS Hospitals, Haslev Coordinator of this site? Confirm its status | Haslev | Denmark | Unknown status |
| The Danish MS Hospitals, Ry Coordinator of this site? Confirm its status | Ry | Denmark | Unknown status |
| MS Ireland Coordinator of this site? Confirm its status | Dublin | Ireland | Unknown status |
| Tel Aviv University Coordinator of this site? Confirm its status | Tel Aviv | Israel | Unknown status |
| University of Cagliari Coordinator of this site? Confirm its status | Cagliari | Italy | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.